|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 18513389 | PON1 | PON1 | 1.8 | 480C T LPL 93 T/G, T G asp9asn asn291ser ser447term PON1 met55leu gln192arg PON2 ser311cys LDLR NcoI+/-, NcoI - CETP-631C/A, CETP-631C | |  |
| 18513389 | PON1 | PON1 | 1.8 | lipase (LPL) LPL asp9asn (chromosome chromosome 8p22 paraoxonase 1 (PON1) PON1 met55leu and paraoxonase 2 (PON2) PON2 ser311cys (chromosome chromosome 7q21.3 | | |
| 18513389 | PON1 | PON1 | 1.8 | 3 adrenergic receptor (ADRB3) ADRB3 trp64arg (8p12-p11.2); 8p12-p11.2 LPL ser447term PON1 gln192arg low density lipoprotein receptor (LDLR) LDLR (chromosome chromosome 19p13.3 | | |
| 18513389 | PON1 | PON1 | 1.8 | paroxonase in predisposing to ALS disease appears to be confirmed PON1 met 55leu and PON2 ser311cys were chosen four times whereas | | |
| 18513389 | PON1 | PON1 | 1.8 | met 55leu and PON2 ser311cys were chosen four times whereas PON1 gln192arg was never | | |
| 18513389 | PON1 | PON1 | 1.8 | had already been picked up by the systems e.g for PON1 NOS and TNF | | |
| 18513389 | PON | PON | 1.8 | confirm some of the already known results (ApoE ApoE and PON for example and identify new gene/genetic gene genetic variations not | | |
| 18513389 | paraoxonase | paraoxonase | 1.0 | genetic variants selected four times over five experiments consisted of: peroxisome proliferator activated receptor gamma pparg pro12ala chromosome 3p25 lipoprotein lipase lpl asp9asn chromosome 8p22 paraoxonase 1 pon1 met55leu and paraoxonase 2 pon2 ser311cys chromosome 7q21.3 tumor necrosis factor beta tnf beta thr26 asn chrom 6p21.3 methylenetetrahydrofolate reductase mthfr 677 c/t chrom 1p36.3 angiotensi | | |
| 18513389 | paraoxonase | paraoxonase | 1.0 | 1 pon1 met55leu and paraoxonase 2 pon2 ser311cys chromosome 7q21.3 tumor necrosis factor beta tnf beta thr26 asn chrom 6p21.3 methylenetetrahydrofolate reductase mthfr 677 c/t chrom 1p36.3 angiotensin ii receptor type1 agtr1 1166 a | | |
| 18513389 | paraoxonase 1 | paraoxonase 1 | 1.0 | genetic variants selected four times over five experiments consisted of: peroxisome proliferator activated receptor gamma pparg pro12ala chromosome 3p25 lipoprotein lipase lpl asp9asn chromosome 8p22 paraoxonase 1 pon1 met55leu and paraoxonase 2 pon2 ser311cys chromosome 7q21.3 tumor necrosis factor beta tnf beta thr26 asn chrom 6p21.3 methylenetetrahydrofolate reductase mthfr 677 c/t chrom 1p36.3 angiotensin | | |